This is the first class of non-opioid pain medication approved to treat moderate to severe acute pain approved by the FDA in more than 20 years. “Today’s approval is an important public health ...

Anxiety symptoms can be distressing and can adversely impact your life. Though treatment needs will differ from person to person, there are many techniques for coping with anxiety that you can try on ...

The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx (suzetrigine) ...

The two most common causes of non-cardiac chest pain include ... a doctor may ask you to consider a prescription. Anti-anxiety medications have side effects and risks. But using them as a stopgap ...

Two doctors have been referred to the Health Sciences Authority for investigations. Read more at straitstimes.com.

The Food and Drug Administration (FDA) has not approved Benadryl, which contains the active ingredient diphenhydramine, to treat anxiety. The medication is also not intended for long-term use.

"Our findings indicate a new and important target for the treatment of anxiety-related disorders and show that our photopharmacology-based approach holds promise more broadly as a way to precisely ...

Background: Non-concordance with medication remains a major public health problem that imposes a considerable financial burden on the health care system, and there is still a need for studies on ...

(CNN) – The U.S. Food and Drug Administration approved the first new type of pain medication in more than two decades, and it’s not an opioid. The drug is suzetrigine under the brand name Journavx. It ...

(NEW YORK) — The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx ...